Home
Enveda

Enveda Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainenveda.com

Year Founded2019

Employees201 - 500

Annual Revenue--

Enveda

Enveda (including company regionals)

enveda.com

See more website traffic and engagement information

Total visits to Enveda's top domains

Understand Enveda market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

enveda.com28.5K

See more with Sales Intelligence

Avg. visit duration in Enveda's top domains

Analyze Enveda engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

enveda.com00:00:51

See more with Sales Intelligence

Avg. pageviews on Enveda's top domains

See how Enveda keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

enveda.com1.77

See more with Sales Intelligence

Enveda top competitors by domain

Top similar sites in June 2026, ranked by their affinity

biopharmadive.comCompany NameBioPharma DiveEmployees51 - 200HQUnited States, Washington, WashingtonAnnual revenue$10M - $15MTotal visits200.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Enveda

These are the website technologies, by industry, used by Enveda top domains

Advertising (5)

Google Adsense

Marketing (4)

Google Marketing Platform

Audio Video Media (3)

YouTube

Content Management System (3)

WordPress

More Technologies

10

See all

News & Signals from Enveda

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEnveda attends event AAD Innovation Academy.Enveda's positive Phase 1B results for ENV-294, a potential first-in-class oral therapy for moderate-to-severe atopic dermatitis, were presented at AAD Innovation Academy; additional details to be shared at EADV.

NewsEnveda Therapeutics, Inc. is developing AI-driven mosquito insecticides for malaria control on Jun 22nd '26.Purdue and Enveda launch project to develop AI-driven mosquito insecticides for malaria control.

NewsPurdue University partnered with Enveda Therapeutics, Inc. on Jun 22nd '26.The three-year project will combine Purdue's expertise in high-throughput screening of anti-mosquito chemistries with the innovative, AI-driven platform of biotechnology partner Enveda.